iShares Trust - iShares Nasdaq Biotechnology ETF announced audited earnings results for the full year ended March 31, 2019. For the full year, the company announced net investment income was USD 12,909,077 compared to USD 13,084,585 a year ago. Net increase in net assets resulting from operations was USD 348,235,411 compared to USD 790,487,536 a year ago.